文献速递白血病

大型病例对照研究表明KIR基因型与急性髓系白血病发病风险无关

Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2023-01-01

该研究分析了1767例德国急性髓系白血病(AML)患者与51890名德国骨髓库志愿者的KIR和HLA基因型,采用高分辨率扩增子二代测序进行分型。未发现两组在单个KIR基因存在与否、主要单倍型A/A、A/B、B/B分布以及受体-配体模型上存在显著差异,结果提示KIR/KIR-配体基因型对原发AML易感性无影响。

要点

  • 大样本病例对照研究未发现单个KIR基因与AML风险相关。
  • 主要单倍型A/A、A/B、B/B在患者与对照中分布均等。
  • 抑制性KIR/KIR-配体配对数量少的轻微保护趋势未达显著。

核心结论

  • 结果表明KIR/KIR-配体基因型对原发急性髓系白血病的易感性没有影响。

研究设计与样本

  • 病例对照研究,纳入1767例德国AML患者与51890名德国骨髓库(DKMS)志愿者对照。
  • 患者样本来自Collaborative Biobank和Study Alliance Leukemia生物样本库。
  • 所有样本采用高分辨率扩增子二代测序进行KIR和HLA基因分型。

主要发现

  • 两组在单个KIR基因存在或缺失方面未发现显著差异。
  • 按端粒或着丝粒基因内容分组,主要单倍型A/A、A/B和B/B在患者与对照间分布均等。
  • 受体-配体模型和求和模型未显示患者与对照间有显著差异,但观察到抑制性KIR/KIR-配体配对数量少具有轻微保护作用的趋势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunogenetic association studies may give rise to new hypotheses on the immune surveillance of cancer. We hypothesized that certain combinations of killer immunoglobulin-like receptor (KIR) and HLA genotypes may enhance natural killer (NK) cell immunity against nascent acute myeloid leukemia (AML) and, thereby, lead to a skewed genotype distribution among patients. For this purpose, we analyzed KIR and HLA genotypes of 1767 German patients with AML and compared the results with that of the data of 51 890 German volunteers who had registered with German bone marrow donor file (DKMS). Patient samples were retrieved from the Collaborative Biobank and the biorepository of the Study Alliance Leukemia. All samples were genotyped with high-resolution amplicon-based next-generation sequencing. Because of the large number of controls, this study was very sensitive to detect the impact of KIR genotype. Knowledge on KIRs and their cognate HLA ligands allowed for testing of several hypotheses of NK cell-mediated endogenous leukemia surveillance. We did not find significant differences between the 2 cohorts in regard to the presence or absence of single KIR genes. When grouped based on telomeric or centromeric gene content, the major haplotypes A/A, A/B, and B/B were equally distributed among patients and control subjects. Using information on KIRs and their HLA ligands, we further tested receptor-ligand models and summation models without revealing markedly significant differences between patients and controls, albeit we observed a trend pointing at a minor protective effect of a low number of inhibitory KIR/KIR-ligand pairs. The results suggest that the KIR/KIR-ligand genotype has no effect on the susceptibility for the development of de novo AML.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Heidenreich F, Falk B, Baldauf H, et al. Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia. Blood Adv. 2023. PMID: 36689727. doi:10.1182/bloodadvances.2022008514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。